AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 1 filers reported holding AVEO PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $2,110,970 | -3.5% | 141,202 | -46.9% | 0.00% | -33.3% |
Q3 2022 | $2,188,000 | +148.6% | 265,882 | +98.2% | 0.00% | +200.0% |
Q2 2022 | $880,000 | +178.5% | 134,156 | +137.4% | 0.00% | – |
Q1 2022 | $316,000 | +71.7% | 56,512 | +43.8% | 0.00% | – |
Q4 2021 | $184,000 | – | 39,298 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 3,952,958 | $23,481,000 | 0.99% |
Cormorant Asset Management, LP | 1,000,000 | $5,940,000 | 0.23% |
WealthTrust Axiom LLC | 22,347 | $132,000 | 0.06% |
SECTORAL ASSET MANAGEMENT INC | 100,000 | $594,000 | 0.05% |
Virtu Financial LLC | 24,577 | $146,000 | 0.02% |
PDT Partners, LLC | 61,839 | $367,000 | 0.02% |
SABBY MANAGEMENT, LLC | 26,039 | $155,000 | 0.02% |
MGO ONE SEVEN LLC | 10,000 | $59,000 | 0.01% |
WINTON GROUP Ltd | 45,208 | $269,000 | 0.01% |
Ancora Advisors LLC | 36,350 | $216,000 | 0.01% |